Coping with Viral Diversity in HIV Vaccine Design
نویسندگان
چکیده
منابع مشابه
Coping with Viral Diversity in HIV Vaccine Design
The ability of human immunodeficiency virus type 1 (HIV-1) to develop high levels of genetic diversity, and thereby acquire mutations to escape immune pressures, contributes to the difficulties in producing a vaccine. Possibly no single HIV-1 sequence can induce sufficiently broad immunity to protect against a wide variety of infectious strains, or block mutational escape pathways available to ...
متن کاملCoping with Viral Diversity in HIV Vaccine Design: A Response to Nickle et al
Will Fischer, H. X. Liao, Barton F. Haynes, Norman L. Letvin, Bette Korber Nickle et al. [1] recently reported a computational method for HIV-1 vaccine antigen design; here we compare this method with our previously published vaccine antigen design method [2], using several criteria that we believe to be important for a successful vaccine candidate [2]. The intent of both approaches is to desig...
متن کاملDiversity considerations in HIV-1 vaccine selection.
Globally, human immunodeficiency virus-type 1 (HIV-1) is extraordinarily variable, and this diversity poses a major obstacle to AIDS vaccine development. Currently, candidate vaccines are derived from isolates, with the hope that they will be sufficiently cross-reactive to protect against circulating viruses. This may be overly optimistic, however, given that HIV-1 envelope proteins can differ ...
متن کاملAnti-Carbohydrate HIV Vaccine Design
R. Pantophlet (ed.), HIV Glycans in Infection and Immunity, DOI 10.1007/978-1-4614-8872-9_6, © Springer Science+Business Media New York 2014 Abstract HIV has evolved a number of strong defense mechanisms, including extensive glycosylation of its surface envelope glycoprotein, to evade host immune responses. Nevertheless, the discovery of a series of glycan-dependent broadly neutralizing antibod...
متن کاملChallenges in the Design of a T Cell Vaccine in the Context of HIV-1 Diversity
The extraordinary variability of HIV-1 poses a major obstacle to vaccine development. The effectiveness of a vaccine is likely to vary dramatically in different populations infected with different HIV-1 subtypes, unless innovative vaccine immunogens are developed to protect against the range of HIV-1 diversity. Immunogen design for stimulating neutralizing antibody responses focuses on "breadth...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: PLoS Computational Biology
سال: 2007
ISSN: 1553-7358
DOI: 10.1371/journal.pcbi.0030075